Robert Thomas Dechant - 26 Feb 2026 Form 4 Insider Report for IBEX Ltd (IBEX)

Signature
Lisa Lenstrohm, Attorney-in-Fact
Issuer symbol
IBEX
Transactions as of
26 Feb 2026
Net transactions value
$0
Form type
4
Filing time
27 Feb 2026, 17:14:59 UTC
Previous filing
23 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dechant Robert Thomas Chief Executive Officer, Director C/O IBEX LIMITED, 1717 PENNSYLVANIA AVENUE NW, SUITE 825, WASHINGTON Lisa Lenstrohm, Attorney-in-Fact 27 Feb 2026 0001298255

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IBEX Common Shares Award $0 +18,000 +6.5% $0.000000 293,406 26 Feb 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. 25% of the RSUs vest on July 1, 2026, with 25% of the RSUs vesting annually thereafter for the following three years, provided that the Reporting Person remains in continuous service on each vesting date. Unless otherwise provided, on each vesting date shares of Common Stock will automatically be withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction.